Donald Trump is threatening 100% tariffs on pharmaceutical companies that have not struck deals to lower US drug prices. Drugmakers who enter pricing agreements with the White House and onshore drug production will be exempted from the tariffs. Companies that plan to increase their domestic manufacturing will see a 20% tariff that will increase to 100% in four years. Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries. When teasing policies affecting drug prices, Trump said at the time that “on that alone, we should win the midterms”.

Source: The Guardian April 03, 2026 02:04 UTC